×

21st Century Oncology Announces Joint Venture With Lourdes Health System

FORT MYERS, Fla., March 12, 2015 (GLOBE NEWSWIRE) -- 21st Century Oncology Holdings, Inc. ("21C Holdings" or the "Company"), the largest global, physician led provider of integrated cancer care ("ICC") services, announced that it and its wholly owned subsidiary, 21st Century Oncology of New Jersey, Inc. ("21C"), entered into a joint venture with a wholly owned subsidiary of Our Lady of Lourdes Healthcare Services, Inc. ("OLOL"), a part of the Trinity Health system, on March 2, 2015. 21C will own 70% in a newly formed joint venture entity, and OLOL will hold a 30% equity interest in the newly-formed entity.

Dr. Daniel Dosoretz, Founder and Chief Executive Officer, commented, "OLOL represents the ideal partner for our Southern New Jersey centers with a robust physician network and oncology support infrastructure that will strengthen our ability to deliver best in class cancer care. OLOL, a leading health care provider in the region with more than 50 sites throughout the state of New Jersey, has invested heavily in developing its oncology platform. We look forward to working closely with them as we create the leading cancer care solution for the patients of Southern New Jersey."

About 21st Century Oncology Holdings, Inc.

21st Century Oncology Holdings, Inc. is the largest global, physician led provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2014, the Company operated 180 treatment centers, including 144 centers located in 16 U.S. states. (Source: 21st Century Oncology Holdings, Inc.)

About Lourdes Health System

The Lourdes Health System is one of the region's leading health care providers, recognized nationally for excellence in clinical care and service to the community. The system has two general acute care hospitals, located in Camden and Willingboro, New Jersey, with a full range of medical, cardiovascular, surgical, behavioral health, rehabilitation and long-term acute care services. Lourdes has a network of outpatient facilities and physician practices located in more than 50 sites throughout southern New Jersey. The Lourdes Health System is a member of Trinity Health, a health system serving residents of 21 states.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. Statements preceded by, followed by or that otherwise include the words "believes", "expects", "anticipates", "intends", "projects", "estimates", "plans", "may increase", "forecast" and similar expressions or future or conditional verbs such as "will", "should", "would", "may" and "could" are generally forward-looking in nature and not historical facts. Forward-looking statements are based on management's current expectations or beliefs about the Company's future plans, expectations and objectives, including, but not limited to, certain expected financial results and estimates. These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause the actual results to differ materially from those projected in these forward-looking statements including, but not limited to reductions in Medicare reimbursement, healthcare reform, decreases in payments by managed care organizations and other commercial payers and other risk factors that may be described from time to time in the Company's filings with the Securities and Exchange Commission. Readers of this release are cautioned not to place undue reliance on forward-looking statements contained herein, which speak only as of the date stated, or if no date is stated, as of the date of this press release. The Company undertakes no obligation to publicly update or revise the forward-looking statements contained herein to reflect changed events or circumstances after the date of this release, unless required by law.

CONTACT: 21st Century Oncology Contact: Richard Lewis SVP, CFO for U.S. Operations 239-931-7281 richard.lewis@21co.com Investor Contact: The Ruth Group Nick Laudico 646-536-7030 nlaudico@theruthgroup.com Courtney Dugan 646-536-7024 cdugan@theruthgroup.comSource:21st Century Oncology Holdings, Inc.